SEP 18, 2015 4:01 PM PDT

How Do Cells Overpower Cancer Drugs?

WRITTEN BY: Ilene Schneider
Cells can adapt to overcome cancer drugs designed to interfere with their genetic controls, according to a study by Cancer Research UK scientists. The findings were published in Epigenetics and Chromatin and reported in Drug Discovery & Development
Some cells have
The study showed that molecular “tags” are normally attached to DNA. These tags send signals to the cell, telling it how to package its DNA and switch genes on or off. Drugs that are known as HDAC inhibitors cause a build-up of certain types of tags, in turn causing potentially damaging changes in gene activity that can kill cancer cells. While these HDAC inhibitors can successfully treat certain types of cancer, such as lymphoma, other types have the ability to survive this disruption.

According to scientists from the University of Birmingham, cells accomplish this by activating an in-built “survival” response to HDAC inhibitors. The response rebalances the tags, maintaining normal gene activity and keeping the cells alive.

Researchers believe that these findings could help to identify which patients are suitable for treatment with these drugs. Additionally, the research could help develop future therapies that override the survival mechanism in tumor types that fail to respond.  

According to lead author Dr. John Halsall, Cancer Research UK scientist from the University of Birmingham, “Our work has shown that some cancer cells can survive the gene damage caused by HDAC inhibitor drugs, so we’ve unveiled a new layer of the cancer cell’s defense that we need to target to destroy tumors. If we work out exactly which types of cancer are vulnerable to these drugs, we can use them in a smarter way to treat patients more effectively.”

Dr. Kat Arney, Cancer Research UK’s science information manager, added, “Working out how genes are switched on and off in cancer is vital if we’re to truly understand and beat the disease. This study could help us tailor how we use HDAC inhibitors so that more patients could benefit from them, and we’ll continue to work towards finding more effective ways to target cancer’s control mechanisms in the future.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUN 15, 2021
Cancer
Red seaweed consumption is associated with a low risk of colon cancer - but why?
JUN 15, 2021
Red seaweed consumption is associated with a low risk of colon cancer - but why?
New research published in Marine Drugs explains why diets high in red seaweed are associated with a low risk of col ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 02, 2021
Cancer
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
SEP 02, 2021
When Cholesterol Doesn't Kill Cancer, it Makes it Stronger!
High cholesterol is associated with an increased risk of several types of cancer, and cancer patients with high choleste ...
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
Loading Comments...